1Pendse S, Ginsburg E, Singh AK. Strategies for preservation of ovarian and testicular function after immunosuppression. Am J Kidney Dis,2004, 43(5): 772-781.
2Kenney LB, Laufer MR, Grant FD, et al. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer, 2001, 91(3): 613-621.
3van den Berg H, Furstner F, van den Bos C, et al. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. Pediatr Blood Cancer, 2004, 42(3):210-215.
4Brinkworth MH, Nieschlag E. Association of cyclophosphamide-induced male-mediated, foetal abnormalities with reduced paternal germ-cell apoptosis. Mutat Res, 2000, 447(2): 149-154.
5Choi YJ, Ok DW, Kwon DN, et al. Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c-kit-expressionin a Fas/FasL and p53 independent manner. FEBS Lett, 2004, 575(1-3): 41-51.
6Kanatsu-Shinohara M, Toyokuni S, Morimoto T, et al. Functional assessment of self-renewal activity of male germline stem cells following cytotoxie damage and serial transplantation. Biol Reprod,2003, 68(5): 1801-1807.
7Kopecky M, Semecky V, Naehtigal P. Vimentin expression during altered spermatogenesis in rats, Acta Histochem, 2005, 107 (4): 279-289.
8Kaneko T, Iuchi Y, Kobayashi T, et al. The expression of glutathione reductase in the male reproductive system of rats supports the enzymatic basis of glutathione function in spermatogenesis. Eur J Biochem, 2002, 269(5): 1570-1578.
9Aguilar-Mahecha A, Hales BF, Robaire B. Effects of acute and chronic cyclophosphamide treatment on meiotic progression and the induction of DNA double-strand breaks in rat spermatocytes. Biol Repred,2005, 72(6): 1297-1304.
10Codrington AM, Hales BF, Robaire B. Spermiogenic germ cell phase-specific DNA damage following cyclophosphamide exposure. J Androl, 2004, 25(3): 354-362.
